Current stock page

Financial Data

JAZZ Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

JAZZJazz Pharmaceuticals plc

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 9/10
$241.55+$1.18 (+0.49%)

Latest quote

  • Momentum
    66
  • Value
    79
  • Quality
    76
  • Risk resilience
    73
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
0
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated —.

Income statement
0 periods

No quarterly history is available for this statement.

Cash flow statement
0 periods

No quarterly history is available for this statement.

Balance sheet
0 periods

No quarterly history is available for this statement.

Key financial metrics
0 periods

No quarterly history is available for this statement.

Financial ratios
0 periods

No quarterly history is available for this statement.

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe67.47x
Pb3.73x
Gross Margin88.17%
Operating Margin20.30%
ROE4.62%
ROIC7.24%
Debt To Equity1.35
FCF Yield10.14%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$241.55
Volume496,703
RSI (14)60.77
MACD5.24
MACD signal1.6
MACD histogram3.63
ADX (14)33.07
SMA (50)$229.13
SMA (200)$220.03
ATR (14)$7.70
Historical volatility (annualized)42.30%
Volume (20-day average)806,002

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score73/100
Beta0.58
Annual volatility38.64%
Max Drawdown-21.62%
Sharpe Ratio1.47
VaR (95%, 1-day)-2.89%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

JAZZ Financial Data FAQ

What is Jazz Pharmaceuticals plc's revenue?

Jazz Pharmaceuticals plc's revenue is one of the core financial data points for JAZZ. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Jazz Pharmaceuticals plc's revenue growing?

Revenue growth shows whether Jazz Pharmaceuticals plc is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is JAZZ's EPS?

JAZZ's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Jazz Pharmaceuticals plc's net income?

Jazz Pharmaceuticals plc's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Jazz Pharmaceuticals plc generate?

Free cash flow shows how much cash Jazz Pharmaceuticals plc generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Jazz Pharmaceuticals plc have?

Cash and debt help frame JAZZ's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.